Displaying drugs 14651 - 14675 of 14943 in total
Bioymifi
Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic. Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.[A257048,A257053]
Investigational
Methylphosphinate
Experimental
Benzoctamine
Benzoctamine is a drug with two main uses. It can be used as a sedative which does not depress the respiratory system, but rather stimulates it. It can also be used as an anxiolytic with the same efficacy as chlordiazepoxide for treating anxiety neurosis.
Experimental
ING-1
ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational
Methyl Methylsulfinylmethyl Sulfide
Experimental
Oleoyl chloride
Experimental
Amitifadine
Investigational
Dimethyl sulfone
Experimental
Investigational
R450
R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational
N-Octyl-2-Hydroxyethyl Sulfoxide
Experimental
2-Cyclopropylmethylenepropanal
Experimental
Methoxyamine
Investigational
Pentanal
Pentanal is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. This drug targets the protein cAMP-dependent protein kinase catalytic subunit alpha.
Experimental
Undecanal
Experimental
Trichloroacetaldehyde
Experimental
PROPYL-1-PHOSPHATE
Experimental
Antimonous acid
Experimental
Methylphosphinic Acid
Experimental
R-348
Investigational
FavId
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational
Lactaldehyde
Experimental
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
Displaying drugs 14651 - 14675 of 14943 in total